Invention Grant
- Patent Title: Sustained release parenteral formulations of buprenorphine
- Patent Title (中): 丁丙诺啡的持续释放非肠道制剂
-
Application No.: US12636227Application Date: 2009-12-11
-
Publication No.: US08455508B2Publication Date: 2013-06-04
- Inventor: Carmela Luangdilok , Douglas R. Flanagan , Luk-Chiu Li , Matthew Widman
- Applicant: Carmela Luangdilok , Douglas R. Flanagan , Luk-Chiu Li , Matthew Widman
- Applicant Address: US IL Abbott Park
- Assignee: Abbott Laboratories
- Current Assignee: Abbott Laboratories
- Current Assignee Address: US IL Abbott Park
- Agency: Michael Best & Friedrich LLP
- Agent Lisa V. Mueller
- Main IPC: A01N43/42
- IPC: A01N43/42 ; A61K31/44

Abstract:
An oil-in-water buprenorphine formulation including buprenorphine and a surfactant that emulsifies the buprenorphine in oil, wherein the drug release is controlled by varying the oil concentration and/or pH. A buprenorphine aqueous suspension formulation including a free base buprenorphine and a suspension stabilizer. A buprenorphine oil formulation including a buprenorphine salt suspended in a pharmaceutically acceptable oil. Methods of providing sustained release of buprenorphine over a period of time.
Public/Granted literature
- US20100093778A1 SUSTAINED RELEASE PARENTERAL FORMULATIONS OF BUPRENORPHINE Public/Granted day:2010-04-15
Information query
IPC分类: